Institute Of Clinical Medicine 1

1. Reperfusion therapy for ST elevation myocardial infarction in low- to middle-income countries: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Association of Preventive Cardiology (EAPC), the ESC Working Group on Thrombosis, and the Stent-Save a Life! Initiative
2. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
4. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
5. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
6. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
7. Management of anaphylaxis due to COVID-19 vaccines in the elderly
8. Management of anaphylaxis due to COVID-19 vaccines in the elderly
9. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
10. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
11. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
12. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
13. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
14. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
15. One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis
16. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
17. Are we closer to achieving precision medicine for migraine treatment? A narrative review
18. A second update on mapping the human genetic architecture of COVID-19
19. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
20. 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
21. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
22. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
23. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
24. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
25. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
26. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
27. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
28. Akt: a key transducer in cancer
29. Correction: Akt: a key transducer in cancer (Journal of Biomedical Science, (2022), 29, 1, (76), 10.1186/s12929-022-00860-9)
30. 2024 ESC Guidelines for the management of chronic coronary syndromes
1